Ovid Therapeutics Inc.OVID

Market cap

$95.29M

P/E ratio

	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	87	36	42	72	188	45	27	26
Marketable securities	-	5	35	-	-	84	79	27
Prepaid expenses and other current assets	1	3	2	3	3	2	4	3
Total current assets	89	44	80	75	190	131	110	56
Long-Term Investments	-	-	-	-	2	6	18	21
Restricted cash	-	-	-	-	2	2	2	2
Right-of-use asset, net	-	-	-	-	-	15	14	13
Property and equipment, net	51,775	69,867	68,363	135,620	242,757	1	768,753	0
Other assets	728,840	391,872	467,247	318,900	164,092	261,191	209,574	0
Total assets	89	48	81	76	195	155	144	92
Accounts payable	2	4	3	5	7	2	4	3
Accrued expenses	4	5	7	12	8	5	7	6
Current portion, lease liability	-	-	-	-	-	533,946	1	1
Total current liabilities	6	9	11	22	15	7	11	11
Lease liability	-	-	-	-	-	16	15	13
Royalty monetization liability	-	-	-	-	-	-	-	-
Total liabilities	-	-	11	32	15	23	56	24
Preferred Stock, Value, Issued	-	-	8	3	1	1	1	-
Common Stock, Value, Issued	24,606	24,654	54,711	65,743	70,359	70,467	70,692	0
Additional paid-in-capital	184	-	-	-	-	358	366	372
Accumulated other comprehensive income (loss)	-	-1,829	2,469	-	-	-42,187	702	-0
Accumulated deficit	-100,715,668	-152,695,278	-213,156,521	-294,192,097	-171	-225	-278	-304
Total stockholders’ equity	83	39	70	44	180	132	88	68
Total liabilities and stockholders’ equity	89	48	81	76	195	155	144	92